HAIR REGROWTH FORMULA SOLUTION

Kraj: Kanada

Język: angielski

Źródło: Health Canada

Składnik aktywny:

MINOXIDIL

Dostępny od:

VITA HEALTH PRODUCTS INC

Kod ATC:

D11AX01

INN (International Nazwa):

MINOXIDIL, TOPICAL

Dawkowanie:

20MG

Forma farmaceutyczna:

SOLUTION

Skład:

MINOXIDIL 20MG

Droga podania:

TOPICAL

Sztuk w opakowaniu:

60ML

Typ recepty:

OTC

Dziedzina terapeutyczna:

MISC. SKIN AND MUCOUS MEMBRANE AGENTS

Podsumowanie produktu:

Active ingredient group (AIG) number: 0114429001; AHFS:

Status autoryzacji:

APPROVED

Data autoryzacji:

2010-09-21

Charakterystyka produktu

_HAIR REGROWTH FORMULA (Minoxidil Topical Solution) _
_Page 1 of 33_
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
HAIR REGROWTH FORMULA
Minoxidil Topical Solution USP
20 mg/mL (2% w/v)
Hair Regrowth Treatment
THIS PRODUCT IS FOR MEN ONLY
VITA HEALTH PRODUCTS INC.
150 Beghin Avenue
Winnipeg, Manitoba
R2J 3W2
Date of Initial Authorization:
June 23, 2010
Date of Revision:
December 20, 2022
Submission Control Number: 269836
_HAIR REGROWTH FORMULA (Minoxidil Topical Solution) _
_Page 2 of 33_
TABLE OF CONTENTS
SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF
AUTHORIZATION ARE NOT LISTED
.
TABLE OF CONTENTS
..............................................................................................................
2
PART I: HEALTH PROFESSIONAL INFORMATION
.....................................................................
4
1
INDICATIONS
..............................................................................................................
4
1.1
Pediatrics
..........................................................................................................
4
1.2
Geriatrics...........................................................................................................
4
2
CONTRAINDICATIONS
.................................................................................................
4
4
DOSAGE AND
ADMINISTRATION.................................................................................
5
4.1
Dosing Considerations
.......................................................................................
5
4.2
Recommended Dose and Dosage
Adjustment..................................................... 5
4.4
Administration...................................................................................................
5
4.5
Missed Dose
......................................................................................................
6
5
OVERDOSAGE
.............................................................................................................
6